These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 21609652

  • 1. Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.
    Pennant M, Orlando R, Barton P, Bayliss S, Routh K, Meads C.
    Health Technol Assess; 2011 May; 15 Suppl 1():43-50. PubMed ID: 21609652
    [Abstract] [Full Text] [Related]

  • 2. Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation.
    Dubois D, Gilet H, Viala-Danten M, Tack J.
    Neurogastroenterol Motil; 2010 Feb; 22(2):e54-63. PubMed ID: 19761492
    [Abstract] [Full Text] [Related]

  • 3. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
    Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L.
    Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
    [Abstract] [Full Text] [Related]

  • 4. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
    Tack J, Camilleri M, Dubois D, Vandeplassche L, Joseph A, Kerstens R.
    Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. What role for prucalopride in constipation?
    Drug Ther Bull; 2011 Aug; 49(8):93-6. PubMed ID: 21831905
    [Abstract] [Full Text] [Related]

  • 8. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
    Cinca R, Chera D, Gruss HJ, Halphen M.
    Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
    [Abstract] [Full Text] [Related]

  • 9. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
    Camilleri M, Van Outryve MJ, Beyens G, Kerstens R, Robinson P, Vandeplassche L.
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.
    Parker M, Haycox A, Graves J.
    Pharmacoeconomics; 2011 Aug; 29(8):719-30. PubMed ID: 21635017
    [Abstract] [Full Text] [Related]

  • 12. Prucalopride: A Review in Chronic Idiopathic Constipation.
    Garnock-Jones KP.
    Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
    [Abstract] [Full Text] [Related]

  • 13. Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia.
    Walker S, Palmer S, Erhorn S, Brent S, Dyker A, Ferrie L, Horsley W, Macfarlane K, White S, Thomas S.
    Health Technol Assess; 2009 Jun; 13 Suppl 1():35-40. PubMed ID: 19567212
    [Abstract] [Full Text] [Related]

  • 14. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M, Kerstens R, Rykx A, Vandeplassche L.
    N Engl J Med; 2008 May 29; 358(22):2344-54. PubMed ID: 18509121
    [Abstract] [Full Text] [Related]

  • 15. Prucalopride. In chronic constipation: poorly documented risks.
    Prescrire Int; 2011 May 29; 20(116):117-20. PubMed ID: 21648173
    [Abstract] [Full Text] [Related]

  • 16. Infliximab for the treatment of adults with psoriasis.
    Loveman E, Turner D, Hartwell D, Cooper K, Clegg A.
    Health Technol Assess; 2009 Jun 29; 13 Suppl 1():55-60. PubMed ID: 19567215
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The use of Resolor (prucalopride) for chronic constipation in women.
    Woodward S.
    Br J Nurs; 2009 Jun 29; 21(16):982, 984-6. PubMed ID: 23123655
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Omalizumab for the treatment of severe persistent allergic asthma.
    Jones J, Shepherd J, Hartwell D, Harris P, Cooper K, Takeda A, Davidson P.
    Health Technol Assess; 2009 Sep 29; 13 Suppl 2():31-9. PubMed ID: 19804687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.